Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?
Merck’s stock price dipped on Oct 30, 2025 even as it delivered a strong third-quarter report. The company posted $17.28 B in Q3 sales and $2.58 adjusted EPS – above analyst forecasts Marketscreener. Sales of Keytruda, its blockbuster cancer drug, grew